8-KOther Events

3M CO 8-K Report, Corporate Update (Mar 8, 2024)

Filed March 8, 2024For Securities:MMM

Summary

3M Company (MMM) has announced a significant strategic move via an 8-K filing on March 8, 2024, detailing the planned spin-off of its Health Care business into a new, independent public company named Solventum Corporation. This separation is a major event for 3M, aiming to unlock shareholder value by allowing each entity to focus on its distinct strategic priorities and markets. The spin-off is structured as a distribution of 80.1% of Solventum's common stock to 3M shareholders.

Key Highlights

  • 13M's Board of Directors has approved the spin-off of its Health Care business, which will operate as Solventum Corporation.
  • 2The spin-off is expected to be completed before the market opens on April 1, 2024.
  • 33M shareholders will receive one share of Solventum common stock for every four shares of 3M common stock held as of the close of business on March 18, 2024 (the record date).
  • 4Cash will be paid in lieu of fractional shares of Solventum common stock.
  • 5The distribution represents 80.1% of Solventum's issued and outstanding shares.
  • 6Completion of the distribution is contingent upon certain conditions being met or waived, as outlined in Solventum's Form 10 Registration Statement.

Frequently Asked Questions

The primary goal of the spin-off is to create two distinct, publicly traded companies (3M and Solventum) that can pursue their respective strategic growth opportunities and capital allocation strategies more effectively, ultimately aiming to unlock shareholder value.

The distribution of Solventum shares to 3M shareholders is expected to occur prior to the opening of trading on April 1, 2024. The record date for determining which shareholders are entitled to receive the Solventum shares is the close of business on March 18, 2024.

For every four shares of 3M common stock you hold as of the close of business on March 18, 2024, you will receive one share of Solventum common stock. Cash will be provided for any fractional shares.

Yes, 3M will distribute 80.1% of the issued and outstanding shares of Solventum Corporation to its shareholders. This means 3M will no longer hold a majority stake in the Health Care business post-spin-off.